NCT00135772View on ClinicalTrials.gov

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
Trial Locations (1)

08854

UMDNJ - Robert Wood Johnson Medical School, Piscataway

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00135772 - Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 | Biotech Hunter | Biotech Hunter